• Navigated unpredictable global geopolitics, including trade wars, tariff wars, currency wars, and military conflicts
• Developed new devices and technologies to create new medical technology and revenue platforms for the future
• Maintained sales focus in preparation for the inevitable recovery after a disappointing FY25 decrease in sales

Uscom Ltd, a leading medical technology company, has provided an update on its FY25 performance and future drivers at its Annual General Meeting. The company faced a challenging global environment, navigating unpredictable geopolitics, including trade wars, tariff wars, currency wars, and military conflicts across multiple continents and markets. Despite these challenges, the company maintained its sales focus in preparation for the inevitable recovery. While the FY25 decrease in sales was disappointing, Uscom devices continue to save lives, change medical practice, and improve the understanding of clinical medicine. The company has developed new devices and planned new technologies to create new medical technology and revenue platforms for the future. Uscom's global footprint, including partnerships with Foxconn and Sinopharm, as well as collaborations with leading hospitals and universities, position the company for future growth. The company remains committed to its mission of improving global healthcare and is proud of the contributions of its global team and investors.

Uscom is focused on expanding its global footprint, strengthening partnerships, and developing innovative products to drive future growth. The company is exploring opportunities in key markets, including China, Southeast Asia, and the US, and is working to diversify its revenue streams and hedging against currency and geopolitical risks.